Biocon’s Malaysia Insulin Plant Wins EU Clearance, Company Is Open To PE Investment

 
• By Penelope MacRae

Biocon has received European regulatory clearance for its new Malaysian insulin plant and also said it is open to private-equity investment proposals for its fast-growing biologics division ahead of a planned IPO.

EU_Malaysia_Flags
Biocon has good European clearance for its insulins facility in Malaysia • Source: Shutterstock

More from Archive

More from Generics Bulletin